The Pharmaceutical Journal
Vol 279 pp515-546 No 7477
10 November 2007

The Pharmaceutical Journal, 10 November 2007

OTHER ISSUES
Previous   Next   Back issues

PJ Online home  |  Search PJ Online

 Acrobat Reader

List of Contents

Leading articles
News
News feature

COMMENT
Broad spectrum
Letters


Meetings

Articles

Glow worm (topical observations)

CPD
When confidences should be kept and what constitutes an exception (Code of ethics)

THE SOCIETY
November Council meeting
• Retention fees

News
• Retention fee collection

MEP amendments
Law and ethics bulletin
Official notices
Obituaries
Branch/Society meetings


JOURNAL NOTICE-BOARD   PDF (40K)
Products
Drug recalls (Atenolol / Bisacodyl / Ibuprofen)
Resources
Corrections/Clarifications

Jobs and Classified advertising



Leading Articles   516

PJ   2007;279:516
PDF (30K)


Virtues of transparency... 516
Let us hope that the members of the Royal Pharmaceutical Society, however grudgingly, accept the explanation put forward by the Treasurer that has enabled the Council to decide to peg the increase in the practising retention fee to just below 40 per cent, as opposed to the 50 per cent increase recommended in the summer
PJ   2007;279:516
Full Text

... and the shortcomings of obfuscation 516
While on the subject of transparency, The Journal wishes that it could highlight that a similar openness was being exercised by the pharmaceutical industry
PJ   2007;279:516
Full Text

Top

News & Features   517-524

News summary  517-522
PJ   2007;279:517-522
Headlines   PDF (150K)

Lead stories
-Council agrees to reduce size of retention fee increase
-Tremendous role for pharmacy in new polyclinics, Darzi declares
-Birmingham pharmacies to help cut infant mortality
-Heart failure deaths in elderly not reduced by statin
-£350k deep clean funding to go to Kent hospital
-Scottish contract payments dependent on training

Can the NHS buy fair access to drugs? 523
As a parliamentary committee concludes its inquiry into the work of the National Institute for Health and Clinical Excellence, Tom Moberly looks at some of the issues raised over the course of the inquiry and the problems to be overcome if the NHS is to provide fair access to resources and medicines
PJ   2007;279:523
Full Text   PDF (40K)

Responsible pharmacist
Qualifications and experience needed to become a responsible pharmacist 524
The consultation on the responsible pharmacist regulations looks at issues around absence from the pharmacy as well as the qualifications and experience needed to be a responsible pharmacist. Dawn Connelly reports
PJ   2007;279:524
Full Text   PDF (30K)

Top

Products   525

PJ   2007;279:525
PDF (40K)

Products   525
-SPC changes
-Prescription products
-Counter products
-Discontinued products
-Supply issues
PJ   2007;279:525
Full Text

Recalls   525
-Atenolol
-Bisacodyl
-Ibuprofen
PJ   2007;279:525
Full Text

Top

Broad Spectrum   526-527

Why knock the National Treatment Agency? Look at its successes! 526
By Terry Maguire
PJ   2007;279:526
Full Text   PDF (30K)

Responsible pharmacist
The “responsible pharmacist” — good for pharmacists and good for patients 527
By Tony Schofield
PJ   2007;279:527
Full Text   PDF (30K)

Top

Letters   528-531

-Retention fees
-Concessionar fees
-Pack sizes
-Prescribing
-Controlled Drugs
-Hospital infections
-Wholesalers
-Locum pharmacy
-BPC
PJ   2007;279:528-531
Full Text   PDF (50K)

Top

Meetings   532, 537

Reports index

Joint Pharmaceutical Analysis Group
What the drug industry thinks about the concept of risk management 532, 537
Joseph Chamberlain reports on what industry representatives think about risk assessment in analytical applications and specific risk areas
PJ   2007;279:532, 537
Full Text   PDF (40K)

Top

Continuing Professional Development (CPD)   533-536

Recent articles

Code of ethics
When confidences should be kept and what constitutes an exception   533-536
In the final article of a series on the 2007 code of ethics, Joy Wingfield discusses the issues around confidentiality and privacy, and how they affect professional boundaries
PJ   2007;279:533-536
Summary   PDF (80K)

Top

Articles   538-539

Landmark drugs
Inderal — a forerunner of a radically new generation of products 538-539
In the second article in a series on landmark drugs, Jenny Bryan discusses the development of Inderal (propranolol) and beta-blockers, and looks at how Inderal was a major advancement in the treatment of hypertension and why it has slowly been superseded by other, newer agents
PJ   2007;279:538-9
Full Text   PDF (60K)

Top

Glow worm   540

PJ   2007;279:540
PDF (40K)


Atlantic MenhadenIs menhaden the most important fish? 540
A lot has been said and written about over-fishing around the world and of the need to encourage diners to switch to species of fish that are more sustainable. Some species are being renamed to make them sound more palatable. For example, the humble pilchard is now the Cornish sardine, while the slimehead has been renamed the orange roughy. One leading retailer has seen sales of the Torbay sole increase dramatically since changing its name from the witch fish
PJ   2007;279:540
Full Text

Do you have any Mandarin? 540
At school I became reasonably fluent in French and German and was advised to take Latin as minority subject as it might have been useful in the study of pharmacy. (I ignored the advice and my pharmacy career did not suffer.)
PJ   2007;279:540
Full Text

Never judge a book by its cover 540
Literary columnist Katy Guest, in a recent article on the Man Booker Prize long list, drew comparisons not only on the style and content of the various works, but also on the cover designs. It may seem futile to think that cover design could have any bearing upon the outcome of the prize itself, yet publishers go to great lengths and expense to ensure that the covers of their publications are striking to the eye and, more importantly, memorable
PJ   2007;279:540
Full Text

Top
The Society    541-546

Also in this section

MEP amendments
Law and Ethics bulletin
Obituaries
Branch/Society meetings

PJ   2007;279:541-546
PDF (310K)

November Council meeting
Council meeting reports

Council agrees to reduce fees for 2008 originally proposed in July 541
PJ   2007;279:541
Full Text 


SOCIETY NEWS

2008 retention fee collection process due to begin next week 542
PJ   2007;279:542
Full Text 

Scotland welcomes newly qualified pharmacists bto the profession 542
PJ   2007;279:542
Full Text 

James Clappison MP visits Council member Graham Phillips's Hertfordshire pharmacy during lung cancer awareness month 543
PJ   2007;279:543
Full Text 

Society and Sense About Science hold fourth reception543
PJ   2007;279:543
Full Text 

Arden House Conference: driving innovation 543
PJ   2007;279:543
Full Text 

Pharmacists at the front line in early detection of lung cancer 544
PJ   2007;279:544
Full Text 


Medicines, Ethics and Practice: a guide for pharmacists
MEP page

November 2007 amendments 542
PJ   2007;279:542
Full Text


Law and Ethics Bulletin 2001 to present
Ensuring adequate professional indemnity insurance cover for professional activities 544
PJ   2007;279:544
Full Text


Official notices 2001 to present

Alteration to the Byelaws: Fees payable to the Society 545
PJ   2007;279:545
Full Text  

Fees to be paid by pharmacy technicians 545
PJ   2007;279:545
Full Text 


Obituaries & tributes 546

Obituaries
-Craine
-Hirst
-Logsdon
-Wallace


PJ   2007;279:546
Full Text 

Top

Diary
Diary / Health events

Branch meetings 545-546
PJ   2007;279:545-546
Full Text 

Society meetings 546
PJ   2007;279:546
Full Text

Top

©The Pharmaceutical Journal